OpGen to Present Antibiotic Resistance Prediction Data at 25th European Congress of Clinical Microbiology and Infectious Dise...
April 12 2017 - 4:30PM
OpGen, Inc. (NASDAQ:OPGN) today announced that five posters
featuring its technologies will be presented at the 25th European
Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
being held April 22-25, 2017 in Vienna, Austria. Among them will be
a poster presentation titled “Prediction of antibiotic resistance
in Escherichia Coli from resistance genes” by Dr. Terry Walker,
Senior Vice President of Research and Development at OpGen. The
presentation will highlight preliminary results supporting OpGen’s
efforts to develop and commercialize a rapid and highly accurate
test that predicts antibiotic resistance using resistance gene
detection and the bioinformatics capabilities of the Acuitas
Lighthouse® Knowledgebase. The OpGen booth location is 32B.
The details for the presentations at ECCMID are as
follows:
Poster title: Prediction of
antibiotic resistance in Escherichia coli from resistance
genesPresenter: T. Walker, OpGen Date and
time: Tuesday, April 25 from 12:54 - 12:59
pm CEST Location: Poster Area
Poster number: #EP0938Abstract
number: #4182 Session info: Direct
detection methods
Poster title: Use of the
Acuitas Resistome Test to detect and type carbapenemase producing
organisms (CPOs): A pilot studyPresenter: G.
Vanstone, Royal Free London NHS Foundation Trust Date and
time: Saturday, April 22 from 3:30 - 4:30
pm CEST Location: Poster Area
Poster number: #P0387Abstract
number: #6205 Session
info: Detection of resistant pathogens
Poster title: Rapid outbreak
detection of multi-drug resistant organisms using resistance genes
profilesPresenter: W. Chang, OpGen Date
and time: Saturday, April 22 from 8:45 am
- 3:30 pm CEST Location: Poster
Area Poster number: #EV0483Abstract
number: #5396 Session
info: Resistance surveillance & epidemiology:
Gram-negatives
Poster title: Evaluation of
QuickFISH and the Sepsityper assays for early identification of
aetiological agents in bloodstream infection in a clinical routine
settingPresenter: A. Pernestig, Systems Biology
Research Centre, University of Skövde Date and
time: Monday, April 24 from 1:30 - 2:30
pm CEST Location: Poster Area
Poster number: #P1561Abstract
number: #1166 Session
info: Diagnostic microbiology
Poster title: Seven years of
clinical experience with the Yeast Traffic Light PNA FISH: assay
performance and implications on antifungal
therapyPresenter: V. Özenci, Karolinska University
Hospital Date and time: Sunday, April
23 from 1:30 - 2:30 pm CEST
Location: Poster Area Poster
number: #P0969Abstract number: #5533
Session info: Diagnostic mycology I
About OpGen OpGen,
Inc. is harnessing the power of informatics and genomic
analysis to provide complete solutions for patient, hospital and
network-wide infection prevention and treatment. Learn more
at www.opgen.com and follow OpGen on Twitter
and LinkedIn.
OpGen Contact:
Michael Farmer
Director, Marketing
240-813-1284
mfarmer@opgen.com
InvestorRelations@opgen.com
OpGen Investor and Media Contact:
MacDougall Biomedical Communications
Cammy Duong
781-591-3443
cduong@macbiocom.com
OpGen (NASDAQ:OPGN)
Historical Stock Chart
From Aug 2024 to Sep 2024
OpGen (NASDAQ:OPGN)
Historical Stock Chart
From Sep 2023 to Sep 2024